Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home-CALM Home-based Treatment With Intravenous Cytarabine for Acute Myeloid Leukemia: Feasibility, Health Economics, Barriers and Facilitators - a National Multicenter Study in Denmark

NCT07802015 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT07802015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home-CALM Home-based Treatment With Intravenous Cytarabine for Acute Myeloid Leukemia: Feasibility, Health Economics, Barriers and Facilitators - a National Multicenter Study in Denmark
Lead sponsor
Zealand University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 17, 2026
Completion date
January 30, 2029
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia (aml), hematologic cancer, home-based chemotherapy, hospital at home